FDA Drug Tracking Unlikely To Improve: Attorneys
While WellPoint Inc.'s plan to monitor rises in health problems among members who take a particular medication will likely be helpful in catching risky side effects, industry initiatives will not curb...To view the full article, register now.
Already a subscriber? Click here to view full article